[good medicine record] good news of consistency evaluation continued, the first one of Jialin "alo" passed, and 5 varieties were undertaken

According to the statistics of pharmaceutical intelligence data, there are 153 acceptance numbers and 68 varieties of consistency evaluation, involving 73 pharmaceutical enterprises, and 31 Acceptance numbers have been passed So what's the trend of this week (May 10 to May 16)? Let's have a look with Xiaobian The consistency of atorvastatin calcium tablets was evaluated Jialin pharmaceutical is the first enterprise to pass the consistency evaluation of atorvastatin calcium tablets It is expected that it will obtain certain support in drug bidding, medical insurance payment and other aspects, which will help to expand the market sales of products, improve market competitiveness and have a positive impact on the company's business performance Atorvastatin calcium tablet is suitable for the patients with hypercholesterolemia and primary hypercholesterolemia As the leader of the lipid-lowering market, it is the only statin drug with a lipid-lowering range of more than 50% and coronary heart disease indications in China According to statistics, from 1998 to 2017, the total sales of the drug in the world was nearly 140 billion US dollars, which was the first heavyweight drug in the history of medicine whose total sales exceeded 100 billion US dollars In 2017, its sales reached US $2.11 billion, an increase of 6.03% year-on-year, ranking fourth in the sales of cardiovascular system drugs in 2017 Through the consistency evaluation, the atorvastatin calcium tablets of Jialin Pharmaceutical Co., Ltd will seize the opportunity in the domestic market and compete with Pfizer's Lipitor market According to the database of registration and acceptance of intelligent drugs, 9 new acceptance numbers of consistency evaluation drugs were added this week, involving 5 varieties They are irinotecan hydrochloride injection of Qilu pharmaceutical, ceftriaxone sodium for injection, metformin hydrochloride tablets of Beijing Jingfeng pharmaceutical, thymus method new for injection of Hainan Shuangzheng pharmaceutical and glimepiride tablets of Jiangsu Wanbang biochemical pharmaceutical Details are as follows: details of undertaking status update: Qilu irinotecan hydrochloride injection irinotecan hydrochloride injection is a drug for advanced colorectal cancer, the original research company is Pfizer (Perth) Pty Limited in Australia According to the pharmaceutical intelligence data, at present, there are only five domestic enterprises that have obtained the approval documents for the production of the drug, namely Hainan Jinrui Pharmaceutical Co., Ltd., Harbin Pharmaceutical Group Bioengineering Co., Ltd., Shanghai Xidi Pharmaceutical Co., Ltd., Qilu Pharmaceutical Co., Ltd and Jiangsu Hengrui Beijing Jingfeng pharmaceutical metformin hydrochloride tablets Metformin hydrochloride tablets are preferred for type II diabetes, especially obesity type II diabetes, which can not be effectively controlled by diet and exercise alone; for type I or type II diabetes, metformin hydrochloride tablets combined with insulin can increase the hypoglycemic effect of insulin, reduce the amount of insulin, and prevent hypoglycemia; metformin hydrochloride tablets can also be combined with sulfonylurea oral hypoglycemic drugs, There is synergy Metformin is a typical representative of biguanide drugs Because of its unique treatment advantages, it has been recommended by many countries and who as the first-line drug for diabetes patients to control hyperglycemia and the basic drug in combination There are a large number of domestic enterprises for production The thymus method for injection in Hainan Shuangcheng Pharmaceutical Co., Ltd is a new drug for the treatment of chronic hepatitis B and the enhancement of immune system response It is also a comprehensive two-way immune regulation, superior to thymopentin, which is equivalent to ritaxan The authoritative guidelines at home and abroad recommend a line of drugs According to the statistics of pharmaceutical intelligence database, there are only three enterprises in China that have obtained the approval documents for the production of the drug, namely Great Wall Pharmaceutical Co., Ltd of Shanghai industry united group, Tianji biopharmaceutical Co., Ltd of Suzhou Tianma Pharmaceutical Group and Hainan Zhonghe Pharmaceutical Co., Ltd Ceftriaxone sodium for injection (ceftriaxone sodium for injection) is a long-acting and broad-spectrum third-generation cephalosporin drug It is a class a medical insurance drug in China, a 520 base drug in China, and an unrestricted antibiotic The original research company of the drug is Roche company of Switzerland, which has been approved to be listed in more than 110 countries; there are also many enterprises in China to produce and copy it Glimepiride tablet is the second generation of sulfonylurea oral antidiabetic drug It is a special dosage form of glimepiride It only needs to be taken once a day to get 24-hour effective blood glucose control It is widely used in the clinical treatment of type 2 diabetes The original research company is Sanofi According to the pharmaceutical intelligence database, only three pharmaceutical companies in China have obtained production approval documents, namely Beijing anvante pharmaceutical, Chongqing kangkeri pharmaceutical and Institute of toxicants and drugs of Academy of Military Medical Sciences.